Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Xie, Fajun ^a   Liu, Haibo ^a   Zhu, Ying Hui ^a   Qin, Yan Ru ^c   Dai, Yongdong ^a   Zeng, Tingting ^a   Chen, Leilei ^b   Nie, Changjun ^a   Tang, Hong ^d   Li, Yan ^a   Fu, Li ^a,b   Guan, Xin Yuan ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 6; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GPR39 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; GENE OVEREXPRESSION; GPR39 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PREVALENCE; PRIMARY TUMOR; RECEPTOR UPREGULATION; ANIMAL; CELL TRANSFORMATION; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR CELL LINE; UPREGULATION; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICROARRAY ANALYSIS; RECEPTORS, G-PROTEIN-COUPLED; TISSUE ARRAY ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 79951958514     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-86     Document Type: Article

References (30)

1. Enzinger PC, Mayer RJ. Esophageal cancer. The New England journal of medicine 2003, 349(23):2241-2252. 10.1056/NEJMra035010, 14657432.
2. Chen BS, Wang MR, Xu X, Cai Y, Xu ZX, Han YL, Wu M. Transglutaminase-3, an esophageal cancer-related gene. International journal of cancer 2000, 88(6):862-865.
3. Metzger R, Schneider PM, Warnecke-Eberz U, Brabender J, Holscher AH. Molecular biology of esophageal cancer. Onkologie 2004, 27(2):200-206. 10.1159/000076913, 15138356.
4. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. International journal of cancer 1996, 69(3):225-235.
5. Qin YR, Wang LD, Fan ZM, Kwong D, Guan XY. Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J Gastroenterol 2008, 14(12):1828-1835. 10.3748/wjg.14.1828, 2700406, 18350619.
6. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, Tsao SW, Guan XY. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer research 2007, 67(22):10720-10726. 10.1158/0008-5472.CAN-07-2411, 18006814.
7. Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, Fu L, Hu L, Guan XY. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Oncogene 2009, 28(31):2821-2828. 10.1038/onc.2009.137, 19525977.
8. Moechars D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L, Daneels G, Kass S, Ver Donck L, Peeters T, Coulie B. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 2006, 131(4):1131-1141. 10.1053/j.gastro.2006.07.009, 17030183.
9. Popovics P, Stewart AJ. GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 2010,
10. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW. Common structural basis for constitutive activity of the ghrelin receptor family. The Journal of biological chemistry 2004, 279(51):53806-53817. 10.1074/jbc.M407676200, 15383539.
11. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG, Schwartz TW. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007, 148(1):13-20. 10.1210/en.2006-0933, 16959833.
12. Dittmer S, Sahin M, Pantlen A, Saxena A, Toutzaris D, Pina AL, Geerts A, Golz S, Methner A. The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor. The Journal of biological chemistry 2008, 283(11):7074-7081. 10.1074/jbc.M704323200, 18180304.
13. Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell migration. Cellular signalling 2009, 21(7):1045-1053. 10.1016/j.cellsig.2009.02.008, 19249352.
14. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nature reviews 2007, 7(2):79-94. 10.1038/nrc2069, 17251915.
15. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992, 69(2):277-284. 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C, 1728357.
16. Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, Wen JM, Fang Y, Hu L, Guan XY. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. International journal of cancer 2003, 107(6):896-902.
17. Cao ZA, Daniel D, Hanahan D. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC cancer 2002, 2:11. 10.1186/1471-2407-2-11, 113758, 12019035.
18. Burger M, Hartmann T, Burger JA, Schraufstatter I. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene 2005, 24(12):2067-2075. 10.1038/sj.onc.1208442, 15688008.
19. Marin YE, Chen S. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. Journal of molecular medicine (Berlin, Germany) 2004, 82(11):735-749.
20. Spiegelberg BD, Hamm HE. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. Current opinion in genetics & development 2007, 17(1):40-44.
21. Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC, Grandis JR. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer research 2006, 66(24):11831-11839. 10.1158/0008-5472.CAN-06-2876, 17178880.
22. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature medicine 1998, 4(8):909-914. 10.1038/nm0898-909, 9701242.
23. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H, Sato M. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Laboratory investigation; a journal of technical methods and pathology 2004, 84(12):1538-1546. 10.1038/labinvest.3700190, 15492752.
24. Fong LY, Sivak A, Newberne PM. Zinc deficiency and methylbenzylnitrosamine-induced esophageal cancer in rats. J NatI Cancer Inst 1978, 61(1):145-150.
25. Fong LY, Li JX, Farber JL, Magee PN. Cell proliferation and esophageal carcinogenesis in the zinc-deficient rat. Carcinogenesis 1996, 17(9):1841-1848. 10.1093/carcin/17.9.1841, 8824504.
26. Gutierrez C, Ramirez-Parra E, Castellano MM, del Pozo JC. G(1) to S transition: more than a cell cycle engine switch. Current opinion in plant biology 2002, 5(6):480-486. 10.1016/S1369-5266(02)00301-1, 12393009.
27. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell proliferation 2003, 36(3):131-149. 10.1046/j.1365-2184.2003.00266.x, 12814430.
28. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39(3):305-318. 10.1080/00313020701329914, 17558857.
29. Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. International journal of oncology 2005, 27(5):1329-1339.
30. Liebmann C. G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts. Current pharmaceutical design 2004, 10(16):1937-1958. 10.2174/1381612043384367, 15180530.